Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control
- PMID: 19460053
- DOI: 10.1111/j.1445-5994.2009.01980.x
Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control
Abstract
Aim: To investigate trends in bladder cancer incidence, mortality and survival, and cancer-control implications.
Methods: South Australian Registry data were used to calculate age-standardized incidence and mortality rates from 1980 to 2004. Sociodemographic predictors of invasive as opposed to in situ disease were examined. Determinants of disease-specific survival were investigated using Kaplan-Meier estimates and proportional hazards regression.
Results: Incidence rates for invasive cancers decreased by 21% between 1980-84 and 2000-04, similarly affecting men and women. Meanwhile increases occurred for combined in situ and invasive disease. While mortality rates decreased by approximately a third in men and women less than 70 years of age after the early 1990 s, no changes were evident for older residents. The proportion of cancers found at an in situ stage was higher in younger ages and more recent diagnostic periods. Five-year survivals of invasive cases decreased from 64% for 1980-84 diagnoses to 58% for 1995-2004. Multivariable analysis showed that diagnostic period was not predictive of survival after age adjustment (P= 0.719), with lower survival relating to older age, transitional compared with papillary transitional cancers, female sex, indigenous status and a country as opposed to metropolitan residence.
Conclusions: Reductions in invasive disease incidence may be due to increased detection at an in situ stage. The decline in survival from invasive disease in more recent periods is explained by increased age at diagnosis. Poorer outcomes of invasive cases remain for women after adjusting for age, histology, indigenous status and residential location.
Similar articles
-
Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006.Acta Oncol. 2010 Jun;49(5):655-64. doi: 10.3109/02841860903575299. Acta Oncol. 2010. PMID: 20156116
-
Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.Aust N Z J Public Health. 2008 Aug;32(4):383-9. doi: 10.1111/j.1753-6405.2008.00260.x. Aust N Z J Public Health. 2008. PMID: 18782405
-
Current trends in bladder cancer in England and Wales.J Urol. 2004 Sep;172(3):1051-5. doi: 10.1097/01.ju.0000136376.11896.62. J Urol. 2004. PMID: 15311036
-
Socioeconomic differences in cancer survival: a review of the evidence.IARC Sci Publ. 1997;(138):177-206. IARC Sci Publ. 1997. PMID: 9353665 Review.
-
Female bladder cancer: incidence, treatment, and outcome.Curr Opin Urol. 2010 Sep;20(5):404-8. doi: 10.1097/MOU.0b013e32833c7a9b. Curr Opin Urol. 2010. PMID: 20592613 Review.
Cited by
-
CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.Int J Oncol. 2017 Jul;51(1):75-90. doi: 10.3892/ijo.2017.4003. Epub 2017 May 17. Int J Oncol. 2017. PMID: 28534984 Free PMC article.
-
MicroRNA-3648 Is Upregulated to Suppress TCF21, Resulting in Promotion of Invasion and Metastasis of Human Bladder Cancer.Mol Ther Nucleic Acids. 2019 Jun 7;16:519-530. doi: 10.1016/j.omtn.2019.04.006. Epub 2019 Apr 14. Mol Ther Nucleic Acids. 2019. PMID: 31071528 Free PMC article.
-
Aberrant expression of microRNAs in bladder cancer.Nat Rev Urol. 2013 Jul;10(7):396-404. doi: 10.1038/nrurol.2013.113. Epub 2013 May 28. Nat Rev Urol. 2013. PMID: 23712207 Review.
-
Identification of a potentially functional circRNA-miRNA-mRNA regulatory network for investigating pathogenesis and providing possible biomarkers of bladder cancer.Cancer Cell Int. 2020 Jan 29;20:31. doi: 10.1186/s12935-020-1108-3. eCollection 2020. Cancer Cell Int. 2020. PMID: 32015691 Free PMC article.
-
The effect of miR-124-3p on cell proliferation and apoptosis in bladder cancer by targeting EDNRB.Arch Med Sci. 2019 Sep;15(5):1154-1162. doi: 10.5114/aoms.2018.78743. Epub 2018 Oct 3. Arch Med Sci. 2019. PMID: 31572460 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical